Corpus overview


MeSH Disease

Human Phenotype


There are no transmission terms in the subcorpus


There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    Questionnaire assessment helps the self-management of patients with inflammatory bowel disease MESHD during the outbreak of Coronavirus Disease MESHD 2019

    Authors: Meiping Yu; Zhenghao Ye; Yu Chen; Tingting Qin; Jiguang Kou; Dean Tian; Fang Xiao

    doi:10.1101/2020.03.25.20043364 Date: 2020-03-27 Source: medRxiv

    Background and Aims: The outbreak of Coronavirus Disease MESHD 2019 (COVID-19) may affect the disease status of patients with inflammatory bowel disease MESHD ( IBD MESHD). This study aimed to assess the disease status of IBD MESHD patients in Hubei province by questionnaire online and guide to the self-management of IBD MESHD patients during this epidemic. Methods: A questionnaire was designed containing the Harvey-Bradshaw Index (HBI), the Partial Mayo Score (PMS), the short inflammatory bowel disease MESHD questionnaire (SIBDQ) and distributed to Hubei IBD MESHD patients online within one month of traffic control after the outbreak of COVID-19. This questionnaire also included some questions about patients' self-report disease conditions and their epidemiological history of COVID-19. Results: A total of 102 eligible questionnaires were included in the analysis. No patient reported infection with severe HP infection with severe MESHD acute respiratory syndrome coronavirus 2 MESHD (SARS-CoV-2) in our study. Our result showed that 69.64% of patients with ulcerative colitis HP ulcerative colitis MESHD ( UC MESHD) and 80.44% of patients with Crohn's disease HP Crohn's disease MESHD ( CD MESHD) were in remission. There was not a statistically significant difference in the proportion of the active disease stage between the two types of disease (p=0.103). The majority of patients (85.29%) had a good health-related quality of life (HRQoL) (SIBDQ[≥]50). The reduction in physical exercise is a risk factor for worsening in conditions (OR=17.593, 95%CI 2.035 to 152.097, p=0.009). Conclusions: The outbreak of COVID-19 might not have a significant impact on most Hubei IBD MESHD patients within one month after the traffic control. The patient's disease condition could be assessed by our questionnaires. Doctors utilized the information and advised for IBD MESHD patients about self-management during the period of COVID-19.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.